Prevision Medicine AG
PrivateLast Round
Grant
Mar 6, 2026
Total Funding Raised
$220,000
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Prevision Medicine AG operates in Healthcare & Life Sciences and is based in Schlieren. Its latest recorded funding round was a Grant round in March 2026.
Prevision Medicine AG is a biotechnology company that provides a functional precision oncology platform to guide personalized cancer treatment decisions.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Prevision Medicine AG Comparables
Compare Prevision Medicine AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| KYAN Technologies | 84% | |
| First Ascent Biomedical | 83% | |
| Travera | 82% |
For institutional investors. Book with your work email.
Prevision Medicine AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 6, 2026 | ||||
| Grant | Nov 6, 2025 | ||||
| Pre Seed | Sep 8, 2025 | ||||
| Angel | Sep 1, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Prevision Medicine AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EPFL Innovation Park | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 24, 2026
Grew 30% QoQ, from 10 to 13 employees.
- Aug 21, 2026
Monthly visitors grew 308% MoM, from 51 to 208.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingSep 24, 2026
Prevision Medicine AG attracted $5.4M in Seed funding from European venture capital firms to boost uptake of its drug screening test, as announced in New York on Sep 24th '26.
For institutional investors. Book with your work email.
Prevision Medicine AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Prevision Medicine AG's valuation, stock price, and market status.
Is Prevision Medicine AG a public or private company?
Prevision Medicine AG is a private company.
What is the current stock price of Prevision Medicine AG?
Prevision Medicine AG is a private company, so its shares have no public market price. Caplight tracks Prevision Medicine AG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Prevision Medicine AG worth (valuation)?
Valuation information for Prevision Medicine AG is not publicly available.
Can I buy Prevision Medicine AG stock?
Prevision Medicine AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Prevision Medicine AG's last funding round?
Prevision Medicine AG's most recent funding round was Grant on March 6, 2026.
Who are the main investors in Prevision Medicine AG?
Key investors in Prevision Medicine AG include EPFL Innovation Park.
Will Prevision Medicine AG IPO soon?
No public IPO plans have been announced for Prevision Medicine AG.
How can I track Prevision Medicine AG secondary market activity?
Caplight tracks bids, offers, and trades in Prevision Medicine AG's shares on secondary markets.